J&J says it filed data with the
A panel of FDA advisers meets next week to consider boosters for both J&J and
The FDA is convening its outside panel of advisers next week to review booster data from both J&J and
MORE ON THE PANDEMIC:
— J&J seeks US clearance for COVID-19 vaccine booster doses
—
— Virus deaths in
See all of AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic
HERE’S WHAT ELSE IS HAPPENING:
The company says the treatment, known as AZD7442, will be the first long-acting antibody combination to receive an emergency use authorization for COVID-19 prevention.
The drugs are lab versions of virus-blocking antibodies that help fight off infections. The treatments help the patient by supplying concentrated doses. The main antibody treatment used in the
Fauci, who is President Joe Biden’s chief medical adviser, says getting the COVID-19 vaccine is no different in concept than receiving other vaccines such as for measles, which have been done for many years. He says a public health review found “very, very few, literally less than a handful” of established religions which actually oppose vaccinations.
Religious exemptions have been on the rise since Biden last month announced sweeping new COVID-19 vaccine mandates covering more than 100 million Americans.
Fauci acknowledges the challenges of businesses to determine if an employee’s claimed religious exemption is more an excuse to bypass legal requirements.
He told Sunday's
Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source